Author

D. P. Saraiva

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Jacinto· 2 shared M. G. Cabral· 2 shared R. Salvador· 2 shared S. Braga· 2 shared A. Antunes· 1 shared B. Assis· 1 shared B. F. Correia· 1 shared I. Negreiros· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Jacinto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Determination of HLA-DR level in cytotoxic T lymphocytes: a new validated tool to predict breast cancer response to treatment

D. P. Saraiva, S. Azeredo-Lopes, A. Antunes, R. Salvador, P. Borralho, B. Assis, I. Pereira, Z. Seabra, I. Negreiros, A. Jacinto, S. Braga, M. G. Cabral

This paper validates HLA-DR expression in cytotoxic T lymphocytes as a predictive biomarker for breast cancer response to neoadjuvant chemotherapy and shows its association with progression-free survival.

bioRxiv · Apr 29, 2021 · PreprintImmunology

Circulating Low Density Neutrophils of Breast Cancer Patients are Associated with their Worse Prognosis due to the Impairment of T cell Responses

D. P. Saraiva, B. F. Correia, R. Salvador, N. de Sousa, A. Jacinto, S. Braga, M. G. Cabral

This study shows that low density neutrophils (LDN) in breast cancer patients are linked to worse prognosis due to their immunosuppressive effects on T cell responses.

bioRxiv · Feb 19, 2021 · PreprintImmunology